10 results · 28ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

OverCEM SA Universal; OverCEM SA Translucent; OverCEM SA Opaque; OverCEM Ti-Abutment; OverCEM Cer-Abutment

FDA 510(k)
FDA Class 2 ·Dental

Novo Surgical

FDA UDI
NOVO SURGICAL, INC.·G586G2423660·deschamps ligature carrier, blunt, left, 8" (20...

MAGIC Infusion Catheter

FDA 510(k)
FDA Class 2 ·Cardiovascular

Puritan OptiTranz Liquid Stuart Collection and Transport System

FDA 510(k)
FDA Class 1 ·Microbiology

ALARIS SYSTEM

FDA Adverse Event
Malfunction ·CAREFUSION SD·Product code FRN·November 2, 2023

COLLEAGUE

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - SINGAPORE·Product code FRN·September 10, 2011

ARTICULEZE M HEAD 36MM +8.5

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS INC US·Product code JDI·November 11, 2014

GYNECARE TVT EXACT CONTINENCE SYSTEM

FDA Adverse Event
Injury ·ETHICON INC.·Product code OTN·July 23, 2013

UNIVERSAL Modular Electric/Battery Handpiece for surgery The electric handpiece is packaged within a foam bag inside of a padded-foam corrugate box. An operating manual is packed with the handpiece between the top foam pad and box lid. A product label is applied to the lid of the box. Product Usage: Surgical instrument motors and accessories are AC-powered, battery-powered, or air-powered devices intended for use during surgical procedures to provide power to operate various accessories or attachments to cut hard tissue or bone and soft tissue. Accessories or attachments may include a bur, chisel (osteotome), dermabrasion brush, dermatome, drill bit, hammerhead, pin driver, and saw blade.

FDA Enforcement
Class II ·Terminated·Zimmer Surgical Inc·November 12, 2014

BioButton REF BIOST06040 with Software version 3.0.20 The BioButton System is a remote monitoring wearable device intended for continuous collection of physiological data in home and healthcare settings while the patient is at rest.

FDA Enforcement
Class II ·Ongoing·Biointellisense Inc.·August 21, 2024